Oral Antiseptic Spray Containing Phthalocyanine Solution Reduced Saliva SARS-CoV-2 Viral Load: Case Series
Int Arch Otorhinolaryngol
.
2022 Jul 14;26(3):e293-e295.
doi: 10.1055/s-0042-1750202.
eCollection 2022 Jul.
Authors
Bernardo da Fonseca Orcina
1
,
Emilene Cristine Izu Nakamura Pietro
2
,
Juliana Pescinelli Garcia Kuroda
2
,
Lucas Marques da Costa Alves
2
,
Mariana Schutzer Ragghianti Zangrando
3
,
Rodrigo Cardoso de Oliveira
4
,
Andréa Name Colado Simão
5
,
Fabiano Vieira Vilhena
6
,
Paulo Sérgio da Silva Santos
1
Affiliations
1
Department of Surgery, Stomatology, Pathology, and Radiology, Faculdade de Odontologia de Bauru da Universidade deSão Paulo, São Paulo, SP, Brazil.
2
Control Infection Comission, Hospital Estadual de Bauru, Bauru, SP, Brazil.
3
Department of Oral Rehabilitation and Periodontology, Faculdade de Odontologia de Bauru da Universidade de São Paulo, São Paulo, SP, Brazil.
4
Department of Oral Biology, Faculdade de Odontologia de Bauru da Universidade de São Paulo, Bauru, SP, Brazil.
5
Department of Immunology, Universidade Estadual de Londrina, Londrina, PR, Brazil.
6
TRIALS Oral Health and Technologies.
PMID:
35846829
PMCID:
PMC9282974
DOI:
10.1055/s-0042-1750202
No abstract available
Grants and funding
Funding
Dr. F. V. Vilhena reports grants from TRIALS Inc, during the conduct of the study; in addition, Dr. F. V. Vilhena has a patent.